Shoichi Shimizu

Dr. Shoichi Shimizu

Department of Immunology and Parasitology, University of Occupational and Environmental Health, Japan, Fukuoka, Japan
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2010 in Malaria Journal
Verified
Journal Article
Open access
PDF file
SSShoichi Shimizu
Shoichi Shimizu
YOYoshio Osada
Yoshio Osada
TKTamotsu Kanazawa
Tamotsu Kanazawa
Yoshiya TanakaYoshiya Tanaka
Yoshiya Tanaka
MAMeiji Arai
Meiji Arai
Background: Azithromycin (AZM) is a macrolide antibiotic that displays an excellent safety profile even in children and pregnant women and has been shown to have anti-malarial activity against blood stage Plasmodium falciparum. This study evaluated the transmission-blocking effect of AZM using a rodent malaria model. Methods: AZM-treated mice infected with Plasmodium berghei were exposed to Anopheles stephensi mosquitoes, followed by the observation of parasite development at different phases in the mosquito, i.e., ookinetes in the midgut, oocysts on the midgut, and sporozoites in the midgut and salivary glands. Furthermore, to evaluate the effect on organelle replication of each stage, quantitative real-time PCR analysis was performed. Results: The inhibitory effect of AZM was noticeable in both gametocyte-ookinete transformation in the midgut and sporozoite production in the oocyst, while the latter was most remarkable among all the developmental phases examined. Real-time PCR analysis revealed that AZM suppressed apicoplast replication at the period of sporozoite production in oocysts. Conclusions: AZM inhibits parasite development in the mosquito stage, probably through the same mechanism as in the liver and blood stages. Such a multi-targeting anti-malarial, along with its safety, would be ideal for mass drug administration in malaria control programmes.

25 November 2022 in Sustainability
Verified
Journal Article
Open access
PDF file
TITomohiro Ishimaru
Tomohiro Ishimaru
SSShoichi Shimizu
Shoichi Shimizu
ATAyaka Teshima
Ayaka Teshima
KIKoki Ibayashi
Koki Ibayashi
MAMihoko Arikado
Mihoko Arikado
MOMakoto Okawara
Makoto Okawara
The coronavirus disease 2019 (COVID-19) pandemic highlighted the importance of health emergency and disaster risk management (EDRM) to reduce the risks and impacts of infectious disease outbreaks. We investigated Japan’s response to the COVID-19 pandemic, focusing on changes made to the current health EDRM. Findings from document analysis and semi-structured interviews with six experts were integrated to provide insights into Japan’s health EDRM to improve outcomes in future health emergencies. Relevant information was extracted from COVID-19 policy documents published by the Japanese government, and the interviews validated and expanded on the data already collected. Challenges faced in the country’s response to COVID-19 and the changes made to the health EDRM framework are summarised. Findings were grouped into human resource topics (including essential health EDRM positions and safety of personnel), health service delivery topics (including public health and hospital primary care services), and logistical topics (including vaccination, personal protective equipment, patient transport, and telecommunications). These responses to the pandemic could serve as an example of good practice for other countries developing strategies for future health emergencies and disasters.

21 December 2021 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
EGEman M. Gaballah
Eman M. Gaballah
KMKentaro Morita
Kentaro Morita
SSShoichi Shimizu
Shoichi Shimizu
AEAbeer A. Elhenawy
Abeer A. Elhenawy
NNNairmen Nabih
Nairmen Nabih
YOYoshio Osada
Yoshio Osada

27 September 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MIMasashi Ikutani
Masashi Ikutani
SSShoichi Shimizu
Shoichi Shimizu
KOKoki Okada
Koki Okada
KIKoshi Imami
Koshi Imami
TITadakatsu Inagaki
Tadakatsu Inagaki
SNSusumu Nakae
Susumu Nakae

8 November 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SKShumpei Kosaka
Shumpei Kosaka
SSShoichi Shimizu
Shoichi Shimizu
SNShingo Nakayamada
Shingo Nakayamada
ANAya Nawata
Aya Nawata
NSNobuyuki Shimono
Nobuyuki Shimono
YTYoshiya Tanaka
Yoshiya Tanaka

12 December 2021 in Asia Pacific Journal of Public Health
Verified
Journal Article
Closed access
PDF file
SSShoichi Shimizu
Shoichi Shimizu
TITomohiro Ishimaru
Tomohiro Ishimaru
MNMasako Nagata
Masako Nagata
AHAyako Hino
Ayako Hino
STSeiichiro Tateishi
Seiichiro Tateishi
YFYoshihisa Fujino
Yoshihisa Fujino
Although multilayered strategies including preventive behaviors should be adopted to mitigate coronavirus disease 2019 (COVID-19) transmission, evidence on the effectiveness of preventive behaviors against COVID-19 remains limited. This Internet-based prospective cohort study collected baseline data in November 2020 and follow-up data in February 2021, during the third wave of the epidemic in Japan. Among the 19 941 included participants, the percentages reporting that they always used a face mask, practiced hand washing/disinfection, gargling, and ensuring proper room ventilation were 85.4%, 36.0%, 51.1%, and 44.6%, respectively. Multiple logistic regression analyses revealed that less frequently practicing hand washing/disinfection (odds ratio [OR] = 1.20), gargling (OR = 1.20), and ensuring proper room ventilation (OR = 1.38) were significantly associated with self-reported COVID-19-like illness (CLI). These results suggest that personal preventive behaviors may be effective in reducing CLI, even when universal masking is practiced.